Use of haloprogin to treat Herpes labialis

Details Use of haloprogin to treat Herpes labialis Use of haloprogin to treat Herpes labialis

1982-09-27

1984-02-28

Goldberg, Jerome D.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Recombinant or stably-transformed bacterium encoding one or...

424 80, A61K 31085, A61K 3179

Patent

active

044341830

ABSTRACT:
Warm-blooded animals are treated for Herpes Simplex Virus-I by administering to the animal a dosage, effective to alleviate the symptoms of the virus, of Haloprogin (chemically called 3-Iodo-2-propynyl-2,4,5-trichlorophenyl ether) and at least one pharmaceutically acceptable carrier, wherein the compound is in the range of from about 0.01 to about 95% by weight of the composition.

REFERENCES:
The Merck Index, 9th Ed., 1976, Merck & Co., Inc., Rahway, N.J., p. 599.

Affiliated with

Also associated with

Rating

Use of haloprogin to treat Herpes labialis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of haloprogin to treat Herpes labialis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of haloprogin to treat Herpes labialis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-759158